It is important to determine the cytotoxicity early in the preclinical phases of drug development. IONTOX provides a range of cytotoxicity testing from standard cell viability screens to multi-endpoint studies. Characterizing test compounds with the range of screens reducing liability because of unforeseen toxicity-related problems. We can helpfully characterize your test compounds from this range of screens to reduce liability due to unforeseen toxicity-related issues. To learn more, visit our website today.